Research and Markets: Progressive Supranuclear Palsy Pipeline Report 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/5k6h89/progressive) has announced the addition of the "Progressive Supranuclear Palsy - Pipeline Insights" report to their offering.

Summary

Progressive Supranuclear Palsy - Pipeline Insights provides in-depth analysis of the pipeline assets across Progressive Supranuclear Palsy. The main objective of this report is to track competitor pipeline molecules, related research activities, technology, collaborations, and in-licensing and out-licensing deals. The Progressive Supranuclear Palsy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Progressive Supranuclear Palsy - Pipeline Insights Report covers the Progressive Supranuclear Palsy pipeline molecules at various stages of development, like pre-registration phase, clinical phases (Phase III, Phase II & Phase I), and pre-clinical and discovery phases. The Report also provides Progressive Supranuclear Palsy related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in the pipeline for Progressive Supranuclear Palsy.

Scope

- The report provides a Progressive Supranuclear Palsy Landscape across the globe

- The report provides drug profiles which include product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Progressive Supranuclear Palsy pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Progressive Supranuclear Palsy and also provides company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/5k6h89/progressive.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals